Strategic Pharmaceutical In-Licensing for Future-Ready Portfolio Growth
Invex Health runs a science-led, asset-light pharmaceutical model, identifying high-potential, off-patent molecules with strong clinical backing, acquiring marketing and distribution rights, and turning them into differentiated, market-ready therapies for international markets.
Strategic In-Licensing
Transforming High-Potential Molecules Into Market-Ready Therapies
A focused model for differentiated pharmaceutical growth. Every opportunity is evaluated on scientific relevance, clinical backing, commercial potential, regulatory feasibility, and long-term portfolio value.
Asset SelectionFocus on off-patent, high-potential molecules with strong clinical backing across targeted therapeutic segments.
Rights Acquisition StrategyAcquiring strategic marketing and distribution rights to accelerate commercialization in targeted international markets.
Commercial Readiness & Co-DevelopmentPartnership-led development that transforms selected assets into market-ready therapies for specialty and differentiated segments.
Market AccessInternational expansion through commercialization pathways across emerging and regulated markets.
Market Research with Quality & Regulatory Support
Data-Driven Portfolio Strategy With Regulatory Rigor
Epidemiological Insights
Market evaluation informed by disease burden, category relevance, and geography-specific healthcare demand.
Competitive Benchmarking
Assessment of the competitive landscape, product positioning, and commercial opportunity across target markets.
Demand Analysis
Selection of licensing opportunities based on market need, growth potential, and commercialization viability.
Regulatory Support
Support for quality dossiers, compliance planning, and regulatory readiness to enable faster go-to-market execution.
Value Driven & Future Focused Investing
Building a Future-Ready Healthcare Portfolio With Accredited Partners
Invex actively invests in high-potential products, breakthrough technologies and forward-thinking partnerships to build a differentiated healthcare portfolio positioned for the next wave of pharmaceutical innovation.
Partner With Invex for Strategic Pharmaceutical In-Licensing and Portfolio Growth
If you're a CMO or licensing partner, connect with Invex Health to discuss high-potential molecules, co-development opportunities, marketing and distribution rights, regulatory support, and international commercialization.